Nventa Develops Proprietary Vaccine Adjuvant

Nventa Develops Proprietary Vaccine Adjuvant

SAN DIEGO, June 18 /PRNewswire/ -- - Potent Adjuvant is a Toll-Like Receptor 3 (TLR3) Agonist Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company has developed a…
Weather Trends Releases Myskeye.com Version 2.0

Weather Trends Releases Myskeye.com Version 2.0

BETHLEHEM, Pennsylvania, June 18 /PRNewswire/ -- - Year-ahead Business Weather Forecasting Portal Weather Trends International Inc. is proud to announce the release of www.myskeye.com version 2.0, a…